submit news    HOME | FEEDBACK  


- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials


- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events

Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here


NanoLogix, Inc., formerly known as Infectech, Inc., is a technology application innovator of biogas products and services designed to assist in worldwide energy independence and reduce pollution from renewable, environmentally-friendly energy sources. NanoLogix is also engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious human diseases. The Company's patents span the identification and antibiotic sensitivity testing of 34 disease-producing bacteria, including M. tuberculosis (TB), Mycobacterium avium-intracellulare (MAI), pseudomonas, and nocardia. These bacteria are cited as prominent causes of morbidity and mortality in patients with cancer, cystic fibrosis, and AIDS. Additionally, NanoLogix owns a patent for the nontoxic induction of apoptosis in cancer cells utilizing hydrophobic hydrocarbons. Apoptosis is a method for inducing a genetically based induction of "cell suicide" in cells.

5/18/2011 10:12:52 AM | Products | 0 comments
Nanologix introduces new "Petri Flat Pack", to exhibit at American Society for Microbiology annual meeting in New Orleans and unveils new website
New packaging method continues NanoLogix revolution of Petri industry for increased quality assurance and more secure shipment
12/13/2010 11:00:16 AM | Partnership | 0 comments
NanoLogix Cooperative Projects Update For EPA and University of Texas Health Science Center Houston
NanoLogix Quick Tests improving result times for Group B Strep
10/19/2010 5:48:11 PM | Bio/Medicine | 0 comments
University of Texas Health Science Center Using NanoLogix Technology in 300 Patient Clinical Trial
NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.
8/16/2005 3:56:17 PM | Industry | 0 comments
NanoLogix Applauds Energy Bill Signing
Recent signing of the energy bill should provide an opportunity for this Nano-biotechnology company
6/1/2005 2:07:57 PM | Patent | 0 comments
NanoLogix Files Hydrogen Production Provisional Patent Application Expanding Its Intellectual Property Portfolio to 32 Patents Issued and Pending in Nanotechnology and NanoBiotechnology
NanoLogix believes they have discovered the most likely method for low cost production of massive quantities of hydrogen as an alternate energy source.
5/25/2005 11:58:35 PM | Products | 0 comments
NanoLogix Unveils Advanced DNA Extraction System for Molecular Diagnostics Market
According to Jain PharmaBiotech, in the year 2005, the global market for molecular diagnostics will be worth $6.5 billion, representing approximately 3.3% of the total diagnostics market and approximately 14% of the in vitro diagnostic market.
5/10/2005 5:06:16 PM | Research | 0 comments
NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor
Laboratory proof-of-concept measurements have shown it possible to generate hydrogen in high yields via the use and adaptation of its intellectual property.

« Back To List »

- submit company
- submit news
- submit events
- advertise here

- More Events

Copyright 2017 | Privacy Policy |